These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1845043)

  • 21. Challenges and strategies for AIDS vaccine development.
    Oxford JS; Frezza P; Race E
    Vaccine; 1993; 11(6):612-4. PubMed ID: 8100664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection against SIV infection in macaques by immunization with inactivated virus from the BK28 molecular clone, but not with BK28-derived recombinant env and gag proteins.
    Mills KH; Page M; Chan WL; Kitchin P; Stott EJ; Taffs F; Jones W; Rose J; Ling C; Silvera P
    J Med Primatol; 1992; 21(2-3):50-8. PubMed ID: 1433267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the specificity of the vaccine effect elicited by inactivated simian immunodeficiency virus.
    Cranage MP; Polyanskaya N; McBride B; Cook N; Ashworth LA; Dennis M; Baskerville A; Greenaway PJ; Corcoran T; Kitchin P
    AIDS Res Hum Retroviruses; 1993 Jan; 9(1):13-22. PubMed ID: 8427714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV vaccine design: insights from live attenuated SIV vaccines.
    Koff WC; Johnson PR; Watkins DI; Burton DR; Lifson JD; Hasenkrug KJ; McDermott AB; Schultz A; Zamb TJ; Boyle R; Desrosiers RC
    Nat Immunol; 2006 Jan; 7(1):19-23. PubMed ID: 16357854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A formalin inactivated whole SIV vaccine and a glycoprotein-enriched subunit vaccine confers protection against experimental challenge with pathogenic live SIV in rhesus monkeys.
    Murphey-Corb M; Martin LN; Davison-Fairburn B; Montelaro RC; Miller M; West M; Ohkawa S; Baskin GB; Zhang JY; Putney S
    Dev Biol Stand; 1990; 72():273-85. PubMed ID: 2282987
    [No Abstract]   [Full Text] [Related]  

  • 26. Alternative interpretation of lymphocyte depletion studies using monoclonal antibodies in animals previously vaccinated with attenuated retroviral vaccines.
    Dittmer U; Hasenkrug KJ
    AIDS Res Hum Retroviruses; 1999 May; 15(8):785. PubMed ID: 10357475
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunotherapy for AIDS virus infections: cautious optimism for cell-based vaccine.
    Bhardwaj N; Walker BD
    Nat Med; 2003 Jan; 9(1):13-4. PubMed ID: 12514710
    [No Abstract]   [Full Text] [Related]  

  • 28. Prolonged clinical latency and survival of macaques given a whole inactivated simian immunodeficiency virus vaccine.
    Hirsch VM; Goldstein S; Hynes NA; Elkins WR; London WT; Zack PM; Montefiori D; Johnson PR
    J Infect Dis; 1994 Jul; 170(1):51-9. PubMed ID: 8014520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus.
    Martinon F; Brochard P; Ripaux M; Delache B; Aurégan G; Vaslin B; Le Grand R
    Vaccine; 2008 Jan; 26(4):532-45. PubMed ID: 18093703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monkey business over AIDS vaccine.
    Weiss R
    BMJ; 1991 Oct; 303(6807):872. PubMed ID: 1933002
    [No Abstract]   [Full Text] [Related]  

  • 31. Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239.
    Abel K; Rourke T; Lu D; Bost K; McChesney MB; Miller CJ
    J Infect Dis; 2004 Nov; 190(9):1697-705. PubMed ID: 15478078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccine protection of rhesus macaques against simian immunodeficiency virus infection.
    Carlson JR; McGraw TP; Keddie E; Yee JL; Rosenthal A; Langlois AJ; Dickover R; Donovan R; Luciw PA; Jennings MB
    AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1239-46. PubMed ID: 2078406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Why do we not have an HIV vaccine and how can we make one?
    Burton DR; Moore JP
    Nat Med; 1998 May; 4(5 Suppl):495-8. PubMed ID: 9585194
    [No Abstract]   [Full Text] [Related]  

  • 34. Intrarectal challenge of macaques vaccinated with formalin-inactivated simian immunodeficiency virus.
    Cranage MP; Baskerville A; Ashworth LA; Dennis M; Cook N; Sharpe S; Farrar G; Rose J; Kitchin PA; Greenaway PJ
    Lancet; 1992 Feb; 339(8788):273-4. PubMed ID: 1346285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIV(mac251) challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen.
    Zhao J; Pinczewski J; Gómez-Román VR; Venzon D; Kalyanaraman VS; Markham PD; Aldrich K; Moake M; Montefiori DC; Lou Y; Pavlakis GN; Robert-Guroff M
    J Virol; 2003 Aug; 77(15):8354-65. PubMed ID: 12857905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic dendritic-cell vaccine for simian AIDS.
    Lu W; Wu X; Lu Y; Guo W; Andrieu JM
    Nat Med; 2003 Jan; 9(1):27-32. PubMed ID: 12496959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of Complement-Mediated Lysis of Simian Immunodeficiency Virus (SIV) and SIV-Infected Cells Reveals Sex Differences in Vaccine-Induced Immune Responses in Rhesus Macaques.
    Miller-Novak LK; Das J; Musich TA; Demberg T; Weiner JA; Venzon DJ; Mohanram V; Vargas-Inchaustegui DA; Tuero I; Ackerman ME; Alter G; Robert-Guroff M
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Live attenuated SIV vaccines are not effective in a postexposure vaccination model.
    Linhart H; Gundlach BR; Sopper S; Dittmer U; Mätz-Rensing K; Kuhn EM; Müller J; Hunsmann G; Stahl-Hennig C; Uberla K
    AIDS Res Hum Retroviruses; 1997 May; 13(7):593-9. PubMed ID: 9135877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a self-inactivating lentiviral vector expressing simian immunodeficiency virus gag for induction of specific immune responses in vitro and in vivo.
    Buffa V; Negri DR; Leone P; Borghi M; Bona R; Michelini Z; Compagnoni D; Sgadari C; Ensoli B; Cara A
    Viral Immunol; 2006; 19(4):690-701. PubMed ID: 17201664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of SIV/deltaB670 glycoprotein-enriched and glycoprotein-depleted subunit vaccines in protecting against infection and disease in rhesus monkeys.
    Murphey-Corb M; Montelaro RC; Miller MA; West M; Martin LN; Davison-Fairburn B; Ohkawa S; Baskin GB; Zhang JY; Miller GB
    AIDS; 1991 Jun; 5(6):655-62. PubMed ID: 1883540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.